King of Prussia, PA, United States of America

Ashok D Patil

This inventor holds 5 USPTO granted patents. Top assignees: Smithkline Beecham Corporation, Harbor Branch Oceanographic Institute. Active years: 1989-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ashok D Patil. Retrieved from https://idiyas.com/inventor/ashok-d-patil

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 1.9

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1989-1998

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Ashok D Patil: Innovator in Retroviral Inhibitors

Introduction

Ashok D Patil is a notable inventor based in King of Prussia, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of retroviral inhibitors. With a total of 5 patents to his name, Patil's work has had a meaningful impact on medical treatments.

Latest Patents

Among his latest patents are innovative compounds such as Coumarin derivatives, which serve as retroviral inhibitors. Additionally, he has developed a Protein Kinase C inhibitor, which relates to the treatment of conditions where Protein Kinase C inhibition is indicated. These inventions showcase his commitment to advancing medical science.

Career Highlights

Throughout his career, Ashok D Patil has worked with prominent organizations, including SmithKline Beecham Corporation and Harbor Branch Oceanographic Institution, Inc. His experience in these companies has allowed him to refine his skills and contribute to groundbreaking research.

Collaborations

Patil has collaborated with esteemed colleagues, including Ponnal Nambi and Kenneth L Rinehart. These partnerships have further enriched his work and expanded the scope of his inventions.

Conclusion

Ashok D Patil is a distinguished inventor whose work in retroviral inhibitors and Protein Kinase C inhibitors has made a significant impact in the pharmaceutical industry. His contributions continue to influence medical treatments and inspire future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…